来自于全球的权威健康专家在近日出版的《柳叶刀》杂志网络版中呼吁疫苗制造商与国际捐助者共同协商肺炎球菌结合疫苗Prevnar的合理定价,同时要求发展中国家政府及其合作伙伴建立疾病监管网络并开始为推广肺炎球菌疫苗做好准备。针对发展中国家肺炎球菌和脑膜炎主要病源的常规免疫可挽救数百万名生命。这些专家一致认为,鉴于肺炎球菌疾病所带来的沉重负担,在全球范围内采取紧急措施推广常规儿童肺炎球菌疫苗是非常必要的。肺炎球菌病是由肺炎链球菌引起的感染;当这种细菌侵犯人体肺脏时,可引起最常见的细菌性肺炎,随后可能侵犯血 In a recent online edition of The Lancet, authoritative health experts from around the world called for vaccine manufacturers and international donors to negotiate a reasonable pricing of pneumococcal conjugate vaccine Prevnar, while requiring developing country governments and their partners to establish Disease surveillance network and began preparing for the promotion of pneumococcal vaccines. Routine immunization against the leading source of pneumococcal and meningitis in developing countries can save millions of lives. These experts agree that in view of the heavy burden of pneumococcal disease, it is imperative to take urgent measures to promote routine pneumococcal vaccines in children worldwide. Pneumococcal disease is an infection caused by Streptococcus pneumoniae; when this bacterium invades the human lung, it can cause the most common bacterial pneumonia, which may subsequently invade the blood